![David Stamler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Stamler
Vorstandsvorsitzender bei
ALTERITY THERAPEUTICS
Vermögen: 12 344 $ am 31.05.2026
Profil
David A. Stamler is Chief Executive Officer, MD & Director at Alterity Therapeutics Ltd. since 2025.
Former roles include Vice President-Clinical Development & Therapeutic at Teva Pharmaceutical Industries Ltd. from 2015 to 2017, Chief Medical Officer at Auspex Pharmaceuticals, Inc. from 2011 to 2015, Chief Medical Officer & Senior Vice President at XenoPort, Inc. from 2008 to 2010, Chief Scientific Officer & Head-Drug Development at Prestwick Pharmaceuticals, Inc. from 2005 to 2008, Senior Global Project Leader-CNS Diseases at Fujisawa Pharmaceutical Co., Ltd. from 2003 to 2005, Vice President-Research & Development at Fujisawa Healthcare, Inc. from 2003 to 2005, Vice President- Clinical Research Center at Astellas Research Institute of America LLC from 2000 to 2003, Director-Clinical Research at Abbott Laboratories from 1993 to 1997.
Education includes undergraduate studies at The University of Chicago and a doctorate from Pritzker School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2026 | 1 904 862 ( 0,02 % ) | 12 344 $ | 31.05.2026 |
Aktive Positionen von David Stamler
| Unternehmen | Position | Beginn |
|---|---|---|
| ALTERITY THERAPEUTICS | Vorstandsvorsitzender | 07.01.2021 |
Ehemalige bekannte Positionen von David Stamler
| Unternehmen | Position | Ende |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2017 |
| AUSPEX PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 05.05.2015 |
| XENOPORT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 19.11.2010 |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
Fujisawa Pharmaceutical Co., Ltd.
 Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals and medical products | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von David Stamler
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals and medical products | Health Technology |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
Alterity Therapeutics Ltd.
 Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fujisawa Healthcare, Inc. | |
Astellas Research Institute of America LLC
 Astellas Research Institute of America LLC Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical research & development company | Commercial Services |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
